Background {#section1-2333721415595789}
==========

Based on 2010 census data, 4.7 million people aged 65 and older in the United States are estimated to have dementia or Alzheimer's disease. With an aging U.S. population, 13.8 million people are expected to have dementia or Alzheimer's disease by 2050 ([@bibr23-2333721415595789]). By 2020, costs for dementia care purchased in the marketplace are expected to exceed US\$129 billion annually ([@bibr25-2333721415595789]).

Responding to this impending upsurge, the United States passed the National Alzheimer's Project Act in 2012 to create a national plan to prevent and treat Alzheimer's disease and other dementias. Key goals in the plan are to prevent and effectively treat Alzheimer's disease and enhance care quality and efficiency ([@bibr51-2333721415595789]). To date, however, medications to reduce or treat memory loss and the behavioral and psychological disturbances that often characterize dementia and Alzheimer's disease show small and inconsistent benefits of uncertain clinical importance and some associated harms ([@bibr27-2333721415595789]; [@bibr28-2333721415595789]; [@bibr44-2333721415595789]). Non-pharmacological interventions, such as those that engage families or caregivers to improve patients' quality of life and to minimize common physical and cognitive symptoms, such as physical and verbal aggression, confusion, wandering, and depression, are often considered to have an impact while being less risky.

Although the caregiver's role in patient care quality is critical, to date the majority of evidence on interventions targeting caregivers of dementia patients have concentrated on effects on *caregiver* health and well-being ([@bibr21-2333721415595789]; [@bibr45-2333721415595789]; [@bibr49-2333721415595789]; [@bibr53-2333721415595789]), not on patient outcomes. A summary of the evidence, therefore, is needed to determine viable strategies for improving patient outcomes. Our goal was to address the following questions: (a) What are the benefits and harms of caregiver psychosocial interventions on outcomes for adults with dementia or Alzheimer's disease compared with usual care or wait list (i.e., efficacy of interventions)? and (b) What are the benefits and harms of a caregiver-involved psychosocial intervention compared with either a patient intervention or another alternative caregiver-oriented intervention (active controls) in improving outcomes for adults with dementia or Alzheimer's disease (i.e., comparative effectiveness of interventions)? The key questions and scope were refined with input from a technical expert panel (TEP) comprised of clinicians, researchers, and policy makers and an earlier, version of our findings is available online (Griffin, 2013).

Method {#section2-2333721415595789}
======

Our systematic review protocol was considered exempt by the Minneapolis VA Institutional Review Board. Because both caregivers and patients could be included as study participants in the studies we reviewed, in our article we refer to the person with dementia or Alzheimer's disease as a "patient" and the person who provides unpaid, direct care and support to patients with dementia or Alzheimer's disease, regardless of relationship, as "caregiver."

Search Strategy {#section3-2333721415595789}
---------------

We searched MEDLINE (Ovid) and PsycINFO for randomized controlled trials (RCTs) published from 1996 through December 2014 using the following search terms: family, couples, caregivers, home nursing, legal guardians, couple therapy, family therapy, or marital therapy (see [Figure 1](#fig1-2333721415595789){ref-type="fig"}). We identified additional citations from reference lists of retrieved articles and from TEP members. We included studies written in the English language and conducted in the United States. We excluded any study with a patient population below age 18 years and any that did not include patients with dementia or Alzheimer's disease.

![Electronic database search strategies.](10.1177_2333721415595789-fig1){#fig1-2333721415595789}

Data Extraction and Quality Assessment {#section4-2333721415595789}
--------------------------------------

Titles, abstracts, and articles were reviewed by study authors. Study and patient characteristics and outcomes data from the included trials were extracted and then verified independently, under the supervision of the principal investigator.

We evaluated study risk of bias using criteria established by the Cochrane Collaboration ([@bibr24-2333721415595789]). Domains included adequate allocation concealment; blinding of interventionists and/or health care providers to study assessments; blinding of assessors to participant intervention arm; whether intent-to-treat (ITT) analyses were used; and whether withdrawals and dropouts by group assignment were adequately described. We also evaluated whether the delivery of interventions was monitored for quality and consistency (i.e., treatment integrity). Trials were rated as good, fair, or poor quality. A good quality trial (low risk of bias) reported adequate allocation concealment, a minimum of single blinding (participants or investigators or assessors are blinded), and either ITT analysis was conducted or clear reasons for dropouts/attrition by group were provided.

We evaluated strength of evidence for each outcome using methods established by the Agency for Healthcare Research and Quality ([@bibr39-2333721415595789]). Strength of evidence was rated as (a) high---further research is very unlikely to change the confidence in the estimate of effect, meaning that the evidence reflects the true effect; (b) moderate---further research may change our confidence in the estimate of effect and may change the estimate; (c) low---further research is very likely to have an important impact on the confidence in the estimate of effect and is likely to change the estimate, meaning that there is low confidence that the evidence reflects the true effect; or (d) insufficient---the evidence was unavailable or did not permit a conclusion. A rating of high strength of evidence indicated that the included studies were low risk of bias RCTs with consistency (i.e., the effect sizes from the included studies were similar and had the same direction, either positive or negative), directness (interventions are directly related to health outcomes of interest), and precision (the degree of certainty surrounding an estimate of effect for each outcome of interest, with uncertainty of the estimate not allowing for a clinically useful conclusion).

Outcomes {#section5-2333721415595789}
--------

The effect of caregiver-involved interventions was evaluated for five patient outcome categories: (a) functional status, (b) quality of life, (c) symptom control, (d) depression/anxiety, and (e) health care utilization. Functional status was defined by multiple indicators, including the patient's physical functioning (e.g., activities of daily living and instrumental activities of daily living) and cognitive functioning (e.g., memory capacity, problem-solving abilities). Patient depression/anxiety included reports of depressive symptoms using standardized assessments. Symptom control or management included reports of behavioral disturbances or problem behaviors associated with dementia (e.g., agitation, wandering, irritability, withdrawn behavior, incontinence, nighttime waking). Health care utilization included hospitalization, institutionalization, or emergency room visits.

Only outcomes that were assessed using previously published scales or measures or had clear end-points (e.g., hospitalization) were included. To determine both immediate benefits and long-term sustainability of the intervention, we captured, whenever possible, data at two time points: post-intervention (±1 month) and greater than 6 months post-intervention. For studies with multiple assessments after 6 months post-intervention, we extracted the last available assessment.

Categorization of Interventions {#section6-2333721415595789}
-------------------------------

We created three categories of interventions based on common characteristics across trials. The first was *caregiver training interventions*, trials that provided training for families to change or manage patient behavior. These interventions typically included developing caregivers' problem-solving skills, strategies to reduce patients' problem behaviors, and skills training to reduce risks or hazards in a patient's environment, but did not focus on supporting caregiver psychosocial needs or support. The second category was *caregiver training and support interventions.* In addition to training caregivers, these interventions often involved cognitive-behavioral techniques to assist caregivers with managing their stress and burden. Interventions included skill building and problem solving for patient safety and behavior as well as coping skills for caregivers. The third category was *unique interventions with unique intervention targets*. These interventions were each highly unique from one another and could not be described within the above categories.

Data Synthesis {#section7-2333721415595789}
--------------

Study findings were summarized for each outcome and within each intervention category. We summarized most findings narratively because the heterogeneity of populations, interventions, and outcomes across studies precluded us from conducting meta-analyses.

We extracted intervention effect sizes from trials when reported. We used [@bibr10-2333721415595789] guide for interpreting magnitude of effect sizes (i.e., *d* of 0.2-0.49 = small effect, 0.5-0.79 = medium effect, 0.8 or greater = large effect). If a trial's effect sizes were not reported, we calculated, whenever possible, intervention effect sizes and corresponding confidence intervals (CIs) using Review Manager version 5.2 software ([@bibr41-2333721415595789]) by entering means, standard deviations, and sample sizes. If an effect size was not significant (the CI included 0), but authors reported significant findings from other statistical tests, we considered the significant test, noting the discrepancy between the effect size and the other test. Given the criticism of systematic reviews for oversimplifying findings and ignoring important differences that do not fit a review's rubric, in cases where other statistical tests were used and effect sizes could not be calculated, the significance of the alternate parameter was noted and used.

Results {#section8-2333721415595789}
=======

From 3,089 citations, we identified 32 references, representing 31 unique RCTs, which met our inclusion criteria (see [Figure 2](#fig2-2333721415595789){ref-type="fig"}). Details on study characteristics, interventions, comparators, and outcomes assessed are found in Supplemental Table 1 or accessed in an earlier and expanded evidence report (Griffin, 2013).

![Literature flow diagram.](10.1177_2333721415595789-fig2){#fig2-2333721415595789}

Description of Trials {#section9-2333721415595789}
---------------------

Baseline characteristics for patients and caregivers are found in [Table 1](#table1-2333721415595789){ref-type="table"}. Overall, trials varied by who provided care, the type of intervention, measures and instruments used to assess outcomes and comparators, and statistical tests for assessing post-intervention differences (e.g., effect sizes, difference in proportions, interaction terms in regression modeling). All but 4 of the 31 trials targeted caregivers of community-dwelling patients and the majority (87%) required patients to meet clinical diagnosis criteria for dementia, although the criteria used varied across trials. Use of a standardized intervention protocol was reported in 58% of trials.

###### 

Summary of Baseline Characteristics (31 Trials).

![](10.1177_2333721415595789-table1)

  Study characteristics                                                                         Total/*M* (range)
  --------------------------------------------------------------------------------------------- --------------------
  No. of patient/caregiver dyads randomized                                                     4,793/154 (36-642)
  No. of patients/caregiver dyads analyzed                                                      4,261/137 (29-518)
  Age of patients, years                                                                        78 (73-86)
  Age of caregivers, years                                                                      65 (48-74)
  Participant marital status, % married                                                         78 (51-100)
  Patient gender, (%) male                                                                      44 (11-65)
  Manualized intervention reported                                                              58% (18/31)
  Caregiver intervention with                                                                   
   Husband/wife or male/female intimate partner only                                            16% (5/31)
   Any identified caregiver                                                                     84% (26/31)
  Caregiver intervention compared with^[a](#table-fn2-2333721415595789){ref-type="table-fn"}^   
   Wait list                                                                                    19% (6/31)
   Usual care                                                                                   45% (14/31)
   Individual treatment                                                                         3% (1/31)
   Other caregiver treatment(s)                                                                 39% (12/31)

*Note.* Four trials included multiple intervention conditions; therefore, total number of comparison conditions exceeds the number of trials.

Some trials included multiple comparison conditions; therefore, groups are not mutually exclusive and, together, exceed 100%.

1.  Key Question 1 (KQ1): What are the benefits/harms of caregiver psychosocial interventions on outcomes for adults with dementia/Alzheimer's disease compared with usual care or wait list?

Twenty trials met our criteria. Fifteen papers from fourteen RCTs compared a caregiver intervention with usual care ([@bibr1-2333721415595789]; [@bibr5-2333721415595789]; [@bibr6-2333721415595789]; [@bibr8-2333721415595789]; [@bibr15-2333721415595789]; [@bibr19-2333721415595789]; [@bibr33-2333721415595789]; [@bibr35-2333721415595789]; [@bibr36-2333721415595789]; [@bibr42-2333721415595789]; [@bibr43-2333721415595789]; [@bibr46-2333721415595789]; [@bibr48-2333721415595789]; [@bibr54-2333721415595789]; [@bibr55-2333721415595789]) and 5 with a wait list control group (i.e., usual care with promise of intervention at completion of study period; [@bibr16-2333721415595789]; [@bibr30-2333721415595789]; [@bibr31-2333721415595789]; [@bibr38-2333721415595789]; [@bibr40-2333721415595789]). One had both a usual care and a wait list control group ([@bibr47-2333721415595789]). Four trials were rated as *good*, 8 as *fair*, and 8 as *poor quality*. Studies ranged in size from 47 to 406 dyads, with a median of 103 per trial. Four trials required the caregiver to be a spouse ([@bibr5-2333721415595789]; [@bibr36-2333721415595789]; [@bibr40-2333721415595789]; [@bibr54-2333721415595789]); others included any caregiver involved in care. Interventions ranged from 1 to 23 sessions, typically lasting 12 to 16 weeks long. Six trials included long-term (at least 6 months) follow-up assessments ([@bibr5-2333721415595789]; [@bibr6-2333721415595789]; [@bibr35-2333721415595789]; [@bibr46-2333721415595789]; [@bibr48-2333721415595789]; [@bibr54-2333721415595789]). However, 1 study, initiated 18 years prior to the paper's publication, reported ongoing follow-up with patients to assess timing to institutionalization ([@bibr35-2333721415595789]).

All studies reported on three or fewer outcomes; none reported on all of our outcomes. The most frequently assessed outcomes were symptom control/management (55%, 11/20 trials; [@bibr6-2333721415595789]; [@bibr8-2333721415595789]; [@bibr15-2333721415595789]; [@bibr17-2333721415595789]; [@bibr19-2333721415595789]; [@bibr33-2333721415595789]; [@bibr36-2333721415595789]; [@bibr38-2333721415595789]; [@bibr40-2333721415595789]; [@bibr42-2333721415595789]; [@bibr55-2333721415595789]) and physical functioning (40%, 8/20 trials; [@bibr5-2333721415595789]; [@bibr6-2333721415595789]; [@bibr15-2333721415595789]; [@bibr29-2333721415595789]; [@bibr31-2333721415595789]; [@bibr36-2333721415595789]; [@bibr46-2333721415595789]; [@bibr55-2333721415595789]). Other outcomes, including cognitive functioning (30%, 6/20 trials; [@bibr31-2333721415595789]; [@bibr38-2333721415595789]; [@bibr40-2333721415595789]; [@bibr43-2333721415595789]; [@bibr47-2333721415595789]; [@bibr48-2333721415595789]), global quality of life (25%, 5/20 trials; [@bibr16-2333721415595789]; [@bibr30-2333721415595789]; [@bibr43-2333721415595789]; [@bibr47-2333721415595789]; [@bibr55-2333721415595789]), depression/anxiety (30%, 6/20 trials; [@bibr16-2333721415595789]; [@bibr30-2333721415595789]; [@bibr33-2333721415595789]; [@bibr43-2333721415595789]; [@bibr46-2333721415595789]; [@bibr47-2333721415595789]), and health care utilization (25%, 5/20 trials; [@bibr1-2333721415595789]; [@bibr5-2333721415595789]; [@bibr35-2333721415595789]; [@bibr54-2333721415595789]; [@bibr55-2333721415595789]), were assessed in less than one third of trials.

Summary of Trials {#section10-2333721415595789}
-----------------

More than half of the 20 trials (55%) reported significant differences in outcomes between usual care and caregiver-involved interventions ([Table 2](#table2-2333721415595789){ref-type="table"}). The cumulative strength of evidence for intervention effectiveness, however, was low for all outcomes ([Table 3](#table3-2333721415595789){ref-type="table"}), due to moderate to high risk of bias and inconsistency and imprecision of the effect sizes calculated. Although single trials had significant effects on outcomes, reported differences were rarely consistent across outcomes or even within different assessments of the same outcome. For example, 11 trials assessed symptom management and 5 found significant differences post-intervention. Of these, 1 trial had a large, significant effect size (0.72; [@bibr16-2333721415595789]; [@bibr30-2333721415595789]; [@bibr47-2333721415595789]; [@bibr55-2333721415595789]). However, others demonstrated a small effect size (1 trial), reported mean differences only (point estimates could not be calculated), or reported significant differences without data being shown (2 trials) to determine the magnitude of effect. Non-significant effect sizes were mostly small in magnitude but had wide CIs (3 trials). In other studies, statistical significance was either not reported or could not be determined (4 trials).

###### 

Outcomes Reported in Trials Comparing Interventions With Caregiver Component Versus Usual Care or Wait List Control.

![](10.1177_2333721415595789-table2)

  Author, year                                                                                          *n*^[a](#table-fn5-2333721415595789){ref-type="table-fn"}^   Study quality^[b](#table-fn6-2333721415595789){ref-type="table-fn"}^   Physical functioning   Cognitive function   Quality of life/overall functioning   Symptom management/control   Depression/anxiety   Utilization
  ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------------------- ---------------------- -------------------- ------------------------------------- ---------------------------- -------------------- -------------
  Caregiver training interventions (*n* = 7)                                                                                                                                                                                                                                                                                                                                    
   Burgener 1998 ([@bibr6-2333721415595789])^[c](#table-fn7-2333721415595789){ref-type="table-fn"}^     54                                                           Poor                                                                   ±                                                                                 ±                                                 
   Gitlin 2001 ([@bibr15-2333721415595789])                                                             202                                                          Poor                                                                   ↔/↑                                                                               ↔/↑                                               
   Gitlin 2008 ([@bibr16-2333721415595789])                                                             60                                                           Good                                                                                                               ↔                                     ↔/↑                          ↔                    
   Martin-Cook 2005 ([@bibr31-2333721415595789])                                                        47                                                           Poor                                                                   ↔                      ↔                                                                                                            
   Quayhagen 2000 ([@bibr40-2333721415595789])^[c](#table-fn7-2333721415595789){ref-type="table-fn"}^   103                                                          Poor                                                                                          ↔                                                          ↔                                                 
   Teri 2005 ([@bibr48-2333721415595789])                                                               95                                                           Fair                                                                                          ↔/↑                  ↔/↑                                                                                     
   Wright 2001 ([@bibr55-2333721415595789])                                                             93                                                           Poor                                                                   ↔                                           ±                                     ↔                                                 ↔
  Caregiver training and support interventions (*n* = 7)                                                                                                                                                                                                                                                                                                                        
   Brodaty 2009 ([@bibr5-2333721415595789])                                                             52                                                           Poor                                                                   ↔                                                                                                                                   ↔
   Gitlin 2010 ([@bibr19-2333721415595789])                                                             272                                                          Fair                                                                                                                                                     ±/↑                                               
   Mittelman 2004 ([@bibr36-2333721415595789]) 2006 ([@bibr35-2333721415595789])                        406                                                          Good                                                                   ±                                                                                 ↔                                                 ↔/↑
   Ostwald 1999 ([@bibr38-2333721415595789])                                                            117                                                          Good                                                                                          ↔                                                          ↔                                                 
   Schmitter-Edgecombe 2014 ([@bibr43-2333721415595789])                                                55                                                           Good                                                                                          ↔/↑                  ↔/↑                                                                ↔                    
   Teri 1997 ([@bibr47-2333721415595789])^[c](#table-fn7-2333721415595789){ref-type="table-fn"}^        72                                                           Fair                                                                                          ↔/↑                                                                                     ↔/↑                  
   Wray 2010 ([@bibr54-2333721415595789])                                                               158                                                          Fair                                                                                                                                                                                                       ↔
  Unique interventions with unique intervention targets (*n* = 6)                                                                                                                                                                                                                                                                                                               
   Bass 2003 ([@bibr1-2333721415595789])                                                                182                                                          Fair                                                                                                                                                                                                       ↔
   Camberg 1999 ([@bibr8-2333721415595789])^[c](#table-fn7-2333721415595789){ref-type="table-fn"}^      54                                                           Fair                                                                                                                                                     ↔                                                 
   Logsdon 2010 ([@bibr30-2333721415595789])                                                            142                                                          Poor                                                                   ↔                                           ↑                                                                  ↑                    
   McCallion 1999 ([@bibr33-2333721415595789])                                                          66                                                           Fair                                                                                                                                                     ↔/↑                          ↔/↑                  
   Robison 2007 ([@bibr42-2333721415595789])                                                            388                                                          Poor                                                                                                                                                     ↑                                                 
   Teri 2003 ([@bibr46-2333721415595789])                                                               153                                                          Fair                                                                   ↔/↑                                                                                                            ↑                    ↔

*Source.* Adapted from evidence report ([@bibr22-2333721415595789]).

*Note*. Ratings: ↑ = treatment significantly better than comparator; ↔ = no significant difference between intervention and comparator; ↓ = treatment significantly worse than comparator; ± = significance not reported or could not be determined; two ratings separated by "/" indicates multiple assessments were used, and the significance of outcomes varied across assessments.

Number randomized.

Good (low risk of bias): The trial reported adequate allocation concealment, a minimum of single blinding (participants or investigators or assessors are blinded), and that either intent-to-treat analysis was conducted or clear reasons for dropouts/attrition by group were provided. Fair (moderate risk of bias): The trial met or was unclear for allocation concealment and blinding with no more than one of the remaining domains (ITT, withdrawals) unmet. A trial with adequate allocation concealment that did not meet other domains was rated fair. Poor (high risk of bias): The trial had inadequate allocation concealment or blinding and/or clearly met only one of the established risks of bias domains.

Multi-arm trials that are also evaluated in KQ2.

###### 

Strength of Evidence for Trials Comparing Intervention With Caregiver Component to Usual Care or Wait List Control.

![](10.1177_2333721415595789-table3)

  Outcome                      No. of studies (*n*^[a](#table-fn9-2333721415595789){ref-type="table-fn"}^)   Risk of bias^[b](#table-fn10-2333721415595789){ref-type="table-fn"}^   Directness^[c](#table-fn11-2333721415595789){ref-type="table-fn"}^   Precision^[d](#table-fn12-2333721415595789){ref-type="table-fn"}^   Consistency^[e](#table-fn13-2333721415595789){ref-type="table-fn"}^   Evidence rating
  ---------------------------- ----------------------------------------------------------------------------- ---------------------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------- --------------------------------------------------------------------- -----------------
  Physical functioning         8 (1,149)                                                                     High                                                                   Direct                                                               Imprecise                                                           Inconsistent                                                          Low
  Cognitive functioning        6 (489)                                                                       Moderate                                                               Direct                                                               Imprecise                                                           Inconsistent                                                          Low
  Quality of life              5 (445)                                                                       Moderate                                                               Direct                                                               Imprecise                                                           Inconsistent                                                          Low
  Symptom control/management   11 (1,815)                                                                    Moderate                                                               Direct                                                               Imprecise                                                           Inconsistent                                                          Low
  Depression/anxiety           6 (548)                                                                       Moderate                                                               Direct                                                               Imprecise                                                           Inconsistent                                                          Low
  Utilization                  6 (1,044)                                                                     Moderate                                                               Direct                                                               Imprecise                                                           Consistent                                                            Low

*Source.* Adapted from evidence report ([@bibr22-2333721415595789]).

Number randomized.

Internal validity. Study design and the quality of individual studies included in the review. Study design limitations may bias the estimates of treatment effect (such as lack of allocation concealment or lack of blinding).

Interventions are directly related to health outcomes of interest.

The degree of certainty surrounding an estimate of effect for each outcome of interest. Uncertainty of effect does not allow for a clinically useful conclusion, and is unable to rule out an important benefit or harm.

The effect sizes from the included studies are similar and have the same direction of effect (positive or negative).

Benefits by Intervention Category {#section11-2333721415595789}
---------------------------------

Seven studies (1 of good quality) assessed caregiver training interventions to improve patient outcomes. Seven (3 of good quality) evaluated caregiver training and support interventions and six (none rated good quality) involved a unique intervention. Details on effect sizes for trials in each intervention category are found in Supplemental Tables 3 to 5.

No one category of intervention appeared to be more effective than another category. Likewise, no one category consistently had significant findings for a specific outcome. In trials that included training to improve caregiving skills, three of seven reported significant improvements in at least one outcome versus comparators ([Table 2](#table2-2333721415595789){ref-type="table"}). One trial of good quality ([@bibr16-2333721415595789]) included training families to tailor activities to the capabilities of dementia patients and reported a large reduction in problem behaviors (*d* = 0.72). Of the trials that utilized both caregiver skill building and caregiver coping and problem solving, four of seven trials reported significant outcomes versus comparators, with two of three being of good quality. One of those trials ([@bibr35-2333721415595789]) found that counseling and support groups for caregivers had persistent and long-term effects on delaying time to nursing home placement compared with usual care controls (unadjusted hazard ratio = 0.71, CI = \[0.54, 0.94\]). The other, a trial that compared a combination of cognitive rehabilitation and multi-family group treatment for patients with mild cognitive impairment and a family member to usual care, reported significant improvements post-intervention in mean scores of everyday functioning and cognitive functioning, but calculated that effect sizes were not significant ([@bibr43-2333721415595789]). None of the unique interventions were rated good quality, but four of six trials reported significant improvements in outcomes over comparators. Effect sizes with CIs were not uniformly reported in these trials.

Benefits and Harms for Outcomes of Interest {#section12-2333721415595789}
-------------------------------------------

### Symptom control {#section13-2333721415595789}

Eleven studies (2 rated good quality; [@bibr16-2333721415595789]) assessed symptom management or control. Effect sizes were reported in 5 of the 11 trials and ranged from −0.19 to 0.72 ([@bibr15-2333721415595789]; [@bibr16-2333721415595789]; [@bibr33-2333721415595789]; [@bibr38-2333721415595789]; [@bibr40-2333721415595789]). Five trials, each using a different assessment for controlling problem behaviors, reported significant improvements compared with usual care or wait list control group ([@bibr15-2333721415595789]; [@bibr16-2333721415595789]; [@bibr19-2333721415595789]; [@bibr33-2333721415595789]; [@bibr42-2333721415595789]; [Table 2](#table2-2333721415595789){ref-type="table"}). Two of the 5 reported significant reductions in either the number or frequency of problem behaviors, with effect sizes ranging from 0.32 to 0.72, respectively ([@bibr15-2333721415595789]; [@bibr16-2333721415595789]). These 2 trials included patients who needed a great deal of assistance with daily tasks and included multi-component interventions with targeted plans for reducing problem behaviors. The other studies that reported significant improvements in symptom management either reported significant interaction between time and comparator group, but not significant effect sizes ([@bibr33-2333721415595789]); reported significant differences across comparator groups, but did not show data ([@bibr42-2333721415595789]); or, reported only mean differences by comparator group ([@bibr19-2333721415595789]).

### Depression {#section14-2333721415595789}

Six trials assessed how interventions affected patient depressive symptoms. Two were good quality ([@bibr16-2333721415595789]; [@bibr43-2333721415595789]), but found no significant difference by comparator group. The remaining four trials, all rated poor or fair quality, used multiple depression assessments and found significant differences in at least one of the depression scales used ([@bibr30-2333721415595789]; [@bibr33-2333721415595789]; [@bibr46-2333721415595789]; [@bibr47-2333721415595789]). The clinical significance of these differences is uncertain. Three trials used unique interventions: a patient exercise promotion intervention ([@bibr46-2333721415595789]); training for effective caregiver visits with institutionalized patients ([@bibr33-2333721415595789]); and, an early-stage memory loss support group for patients and caregivers ([@bibr30-2333721415595789]). The fourth intervention included either behavior therapy and problem solving for caregivers or behavior therapy and training for caregivers to provide pleasant activities for the patient ([@bibr47-2333721415595789]). Because effect sizes and associated CIs were not consistently reported, the magnitude of effects was not always transparent. For example, one trial ([@bibr47-2333721415595789]), which compared the intervention group with both a usual care and wait list arm, reported significant reductions across two different measures of depression, with effect sizes ranging from *d* = −0.86 to −1.4. In another trial ([@bibr46-2333721415595789]), however, no effect size was reported, although the mean difference in depression scale scores was significantly lower for the treatment group after adjustment for baseline depression. In the two other trials ([@bibr30-2333721415595789]; [@bibr33-2333721415595789]), the effect size was reported as significant, but the actual effect size estimate was not provided and CIs were not reported ([@bibr30-2333721415595789]) or the main effect size was not significant, but the intervention group by time interaction was ([@bibr33-2333721415595789]).

### Quality of life {#section15-2333721415595789}

Five trials assessed quality of life. Three trials, varying in methodological quality from good to poor, reported significant improvements in quality of life versus controls ([@bibr30-2333721415595789]; [@bibr43-2333721415595789]; [@bibr48-2333721415595789]). One good quality trial, by [@bibr43-2333721415595789], found improvements in mean scores of everyday functioning, but effect sizes were not significant. A trial by [@bibr30-2333721415595789] compared an early-stage memory loss support group for families with controls consisting of dyads on a support group wait list. Another compared usual care with an intervention with home visits to caregivers to teach them problem-solving strategies to change patient behavior ([@bibr48-2333721415595789]). [@bibr48-2333721415595789] reported effect sizes that were not significant post-intervention, but were at 6 months after treatment, adjusting for baseline and 2-month follow-up assessments. [@bibr30-2333721415595789] reported that effect sizes were statistically significant, but did not report CIs. Another trial that assessed quality of life was rated good quality, and although a large reduction in problem behaviors was found, there was no significant difference in patients' quality of life ([@bibr16-2333721415595789]).

### Physical and cognitive functioning {#section16-2333721415595789}

Two of nine trials, one of poor and the other of fair quality, assessed physical functioning and showed significant improvements compared with controls ([@bibr15-2333721415595789]; [@bibr46-2333721415595789]). The trial by Teri et al. ([@bibr15-2333721415595789]; [@bibr46-2333721415595789]) specifically targeted promotion of exercise to improve symptoms. [@bibr15-2333721415595789] used a multi-component intervention that included modifications of the social and physical environment and a targeted plan to reduce symptoms.

Three of six trials assessing cognitive functioning, one rated good and two rated fair, reported significant improvement versus comparators ([@bibr43-2333721415595789]; [@bibr47-2333721415595789]; [@bibr48-2333721415595789]), but effect sizes were not significant.

### Utilization {#section17-2333721415595789}

Described in more detail below, only one of the six trials assessing health care utilization reported significant differences. In that trial, compared with usual care, patients of caregivers who received counseling and support groups were able to avoid nursing home placement for longer periods of time ([@bibr35-2333721415595789]).

No harm to caregivers or patients was reported in any studies.

Long-Term Outcomes {#section18-2333721415595789}
------------------

Of the six trials that assessed long-term outcomes (\>6 months), three reported persistent intervention effects. Mittelman et al. conducted a large trial that included tailored counseling and ad hoc telephone support for caregivers and followed patients over 18 years. Although the physical functioning and symptom control of patients in the comparator groups did not differ, they found that patients were able to remain at home longer. The intervention group showed a 28.3% less nursing home placement for patients, an equivalent to a delay of 557 days compared with usual care. Of the remaining two trials showing significant long-term outcomes, one noted improvements in cognitive functioning and quality of life after 6 months ([@bibr48-2333721415595789]) and the other found an improvement in physical functioning and depressive symptoms after 2 years ([@bibr46-2333721415595789]).

1.  Key Question 2 (KQ2): What are the benefits of one caregiver-involved psychosocial intervention compared with either a patient intervention or another alternative caregiver-oriented intervention (active controls) in improving outcomes for adults with dementia or Alzheimer's disease?

Summary of Trials {#section19-2333721415595789}
-----------------

We identified 15 trials that met inclusion criteria. Study characteristics and abbreviations are provided in Supplemental Tables 1 and 2, respectively. Although 6 of 15 trials (40%) reported significant differences between interventions for any outcome ([Table 4](#table4-2333721415595789){ref-type="table"}), the cumulative strength of evidence for intervention effectiveness was low for all outcomes ([Table 5](#table5-2333721415595789){ref-type="table"}) due to moderate to high risk of bias, imprecision of the effect size, and poor methodological quality. Non-significant effect sizes were mostly small, though some outcomes had wide CIs and we could not rule out potentially clinically important effects. Data from two trials were not reported or could not be determined from the data reported.

###### 

Outcomes Reported in Trials Comparing Interventions With Caregiver Component to Alternative Caregiver or Patient Interventions.

![](10.1177_2333721415595789-table4)

  Author, year                                                      *n*^[a](#table-fn16-2333721415595789){ref-type="table-fn"}^   Study quality^[b](#table-fn17-2333721415595789){ref-type="table-fn"}^   Physical functioning   Cognitive function   Quality of life/overall functioning   Symptom management/control   Depression/anxiety   Utilization
  ----------------------------------------------------------------- ------------------------------------------------------------- ----------------------------------------------------------------------- ---------------------- -------------------- ------------------------------------- ---------------------------- -------------------- -------------
  Caregiver training interventions (*n* = 5)                                                                                                                                                                                                                                                                                                  
   Bourgeois 2002 ([@bibr3-2333721415595789])                       63                                                            Good                                                                                                                                                      ↔\\↑                                              
   Burgener 1998 ([@bibr6-2333721415595789])                        54                                                            Poor                                                                    ±                                                                                 ±                                                 
   [@bibr9-2333721415595789] ([@bibr9-2333721415595789])            65                                                            Poor                                                                    ↔                                                                                 ↔                                                 
   Gerdner 2002 ([@bibr14-2333721415595789])                        241                                                           Fair                                                                    ±                                                                                 ±                                                 
   Quayhagen 2000 ([@bibr40-2333721415595789])                      103                                                           Poor                                                                                           ↔                                                          ↔                                                 
  Caregiver training and support interventions (*n* = 7)                                                                                                                                                                                                                                                                                      
   Belle 2006 ([@bibr2-2333721415595789])                           518                                                           Fair                                                                                                                ↑                                     ↔                                                 ↔
   Burns 2003 ([@bibr7-2333721415595789])                           76                                                            Poor                                                                                                                                                      ↔                                                 
   Gaugler 2013 ([@bibr13-2333721415595789])                        107                                                           Good                                                                                                                                                                                                        ↑
   Gitlin 2003 ([@bibr17-2333721415595789])                         255                                                           Fair                                                                    ↔                      ↔                                                          ↔                                                 
   Gitlin 2010 ([@bibr18-2333721415595789])                         237                                                           Good                                                                    ↔\\↑                                        ↔                                     ↔                                                 
   Gonyea 2006 ([@bibr20-2333721415595789])                         91                                                            Poor                                                                                           ↔                                                                                                            
   Teri 1997 ([@bibr47-2333721415595789])                           72                                                            Fair                                                                                           ↔                                                                                       ↔                    
  Unique interventions with unique intervention targets (*n* = 3)                                                                                                                                                                                                                                                                             
   Camberg 1999 ([@bibr8-2333721415595789])                         54                                                            Fair                                                                                                                                                      ↔                                                 
   Jirovec 2001 ([@bibr26-2333721415595789])                        118                                                           Poor                                                                                           ↔                                                          ↔/↑                                               
   McCurry 2005 ([@bibr34-2333721415595789])                        36                                                            Good                                                                                           ↔                                                          ↔/↑                          ↔/↑                  

*Source*. Adapted from evidence report ([@bibr22-2333721415595789]).

*Note.* Bourgeois ([@bibr3-2333721415595789]) compared a caregiver intervention with a patient intervention; all other trials compared one caregiver-involved intervention with an alternative caregiver intervention. Ratings: ↑ = treatment significantly better than comparator; ↔ = no significant difference between intervention and comparator; ↓ = treatment significantly worse than comparator; ± = significance not reported or could not be determined; two ratings separated by "/" indicates multiple assessments were used, and the significance of outcomes varied across assessments.

Number randomized.

Good (low risk of bias): The trial reported adequate allocation concealment, a minimum of single blinding (participants or investigators or assessors are blinded), and that either intent-to-treat analysis was conducted or clear reasons for dropouts/attrition by group were provided. Fair (moderate risk of bias): The trial met or was unclear for allocation concealment and blinding with no more than one of the remaining domains (ITT, withdrawals) unmet. A trial with adequate allocation concealment that did not meet other domains was rated fair. Poor (high risk of bias): The trial had inadequate allocation concealment or blinding and/or clearly met only one of the established risks of bias domains.

###### 

Strength of Evidence for Trials Comparing Interventions With Caregiver Component to Alternative Caregiver or Patient Interventions.

![](10.1177_2333721415595789-table5)

  Outcome                      No. of studies (*n*^[a](#table-fn19-2333721415595789){ref-type="table-fn"}^)   Risk of bias^[b](#table-fn20-2333721415595789){ref-type="table-fn"}^   Directness^[c](#table-fn21-2333721415595789){ref-type="table-fn"}^   Precision^[d](#table-fn22-2333721415595789){ref-type="table-fn"}^   Consistency^[e](#table-fn23-2333721415595789){ref-type="table-fn"}^   Evidence rating
  ---------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------- --------------------------------------------------------------------- -----------------
  Physical functioning         5 (852)                                                                        Moderate                                                               Direct                                                               Imprecise                                                           Unknown                                                               Low
  Cognitive functioning        6 (675)                                                                        Moderate                                                               Direct                                                               Imprecise                                                           Consistent                                                            Low
  Quality of life              2 (755)                                                                        Moderate                                                               Direct                                                               Imprecise.                                                          Unknown                                                               Low
  Symptom control/management   12 (1,820)                                                                     Moderate                                                               Direct                                                               Imprecise                                                           Consistent                                                            Low
  Depression/anxiety           2 (108)                                                                        Moderate                                                               Direct                                                               Imprecise                                                           Consistent                                                            Low
  Utilization                  2 (625)                                                                        Moderate                                                               Direct                                                               Imprecise                                                           Inconsistent                                                          Low

*Source.* Adapted from expanded evidence report (Authors, 2013).

Number randomized.

Internal validity. Study design and the quality of individual studies included in the review. Study design limitations may bias the estimates of treatment effects (such as lack of allocation concealment or lack of blinding).

Interventions are directly related to health outcomes of interest.

The degree of certainty surrounding an estimate of effect for each outcome of interest. Uncertainty of effect does not allow for a clinically useful conclusion, and is unable to rule out an important benefit or harm.

The effect sizes from the included studies are similar and have the same direction of effect (positive or negative).

Only one trial compared an individual intervention (i.e., targeting self-change for the caregiver) with a caregiver-involved intervention (i.e., targeting patient behavior; [@bibr3-2333721415595789]). The remaining trials directly compared an active caregiver intervention with either an attention control (typically an education component with or without a supportive phone call; [@bibr2-2333721415595789]; [@bibr7-2333721415595789]; [@bibr9-2333721415595789]; [@bibr17-2333721415595789]; [@bibr18-2333721415595789]; [@bibr20-2333721415595789]; [@bibr34-2333721415595789]; [@bibr13-2333721415595789]), one other caregiver intervention ([@bibr14-2333721415595789]), or multiple alternative caregiver interventions ([@bibr3-2333721415595789]; [@bibr6-2333721415595789]; [@bibr8-2333721415595789]; [@bibr40-2333721415595789]; [@bibr47-2333721415595789]). Four trials were rated as good, five as fair, and six as poor quality. Studies ranged in size from 36 to 518 dyads with a median of 97 per trial. Interventions included 1 to 38 sessions, averaging 9. Two trials included only spousal caregivers ([@bibr3-2333721415595789]; [@bibr40-2333721415595789]); one included only children of care recipients ([@bibr13-2333721415595789]), and all others included any caregiver or primary caregiver involved in care. Two trials ([@bibr13-2333721415595789]; [@bibr47-2333721415595789]) included long-term (at least 6 months post-intervention) follow-up assessments.

No trial reported on all outcomes and most reported on only one or two. The most frequently assessed outcome was symptom control/management (80%, 12/15 trials; [@bibr2-2333721415595789]; [@bibr3-2333721415595789]; [@bibr6-2333721415595789]; [@bibr7-2333721415595789]; [@bibr8-2333721415595789]; [@bibr9-2333721415595789]; [@bibr14-2333721415595789]; [@bibr17-2333721415595789]; [@bibr18-2333721415595789]; [@bibr26-2333721415595789]; [@bibr34-2333721415595789]; [@bibr40-2333721415595789]), followed by cognitive functioning (40%, 6/15 trials; [@bibr17-2333721415595789]; [@bibr20-2333721415595789]; [@bibr26-2333721415595789]; [@bibr34-2333721415595789]; [@bibr40-2333721415595789]; [@bibr47-2333721415595789]), physical functioning (33.3%, 5/15 trials; [@bibr6-2333721415595789]; [@bibr9-2333721415595789]; [@bibr14-2333721415595789]; [@bibr17-2333721415595789]; [@bibr18-2333721415595789]), and global quality of life (20%, 3/15 trials; [@bibr2-2333721415595789]; [@bibr18-2333721415595789]; [@bibr47-2333721415595789]). The remaining outcomes of interest, depression/anxiety and utilization, were each assessed in 13% (2/15) of trials (depression: [@bibr34-2333721415595789]; [@bibr47-2333721415595789]; utilization: [@bibr2-2333721415595789]; [@bibr13-2333721415595789]).

Benefits by Intervention Category {#section20-2333721415595789}
---------------------------------

None of the intervention categories emerged as the superior approach for improving patient outcomes. Details on effect sizes for trials in each intervention category are found in Supplemental Tables 6 to 8. Of the five trials that included caregiver training only, one reported significant improvements in outcomes versus comparators ([@bibr3-2333721415595789]). This good quality trial, described in detail below, showed that training caregivers to manage patient behavior was more effective at improving symptoms than providing caregivers personal strategies to cope with patient behavior. In the second category of trials that included both caregiver training and support, three of six trials, two of good ([@bibr13-2333721415595789]; [@bibr18-2333721415595789]) and one of poor quality ([@bibr2-2333721415595789]), reported significant differences. One good quality trial showed significant improvements in patient outcomes for caregivers who received support and training to reduce environmental stressors at home compared with those who received psychoeducation only over the telephone. The other good quality trial showed less placement in residential care among care recipients of caregivers involved in the study's intervention ([@bibr13-2333721415595789]). In the third category of interventions, two of three unique interventions showed significant differences in symptom control ([@bibr26-2333721415595789]; [@bibr34-2333721415595789]), compared with supportive controls. Each targeted a specific symptom to change (toileting intervention to reduce incontinence and sleep education to reduce nighttime wakening, respectively).

Benefits and Harms of Caregiver Interventions Compared With Individual or Another Caregiver-Involved Intervention {#section21-2333721415595789}
-----------------------------------------------------------------------------------------------------------------

Just more than half of the 15 trials ([@bibr7-2333721415595789]; [@bibr8-2333721415595789]; [@bibr9-2333721415595789]; [@bibr13-2333721415595789]; [@bibr17-2333721415595789]; [@bibr20-2333721415595789]; [@bibr40-2333721415595789]; [@bibr47-2333721415595789]) reported significant differences between comparator groups. Of these, 5 trials reported superior intervention benefits on one outcome of interest ([@bibr2-2333721415595789]; [@bibr3-2333721415595789]; [@bibr13-2333721415595789]; [@bibr18-2333721415595789]; [@bibr26-2333721415595789]), and 1 trial reported benefits for two outcomes ([@bibr34-2333721415595789]; [Table 4](#table4-2333721415595789){ref-type="table"}). Two trials reported significant findings, but did not report their findings with sufficient detail to evaluate differences in outcomes by comparator groups ([@bibr6-2333721415595789]; [@bibr14-2333721415595789]).

The overall strength of evidence for the effectiveness of one intervention compared with an alternative active treatment was low for all outcomes, due to moderate risk of bias and imprecision of the effect size ([Table 5](#table5-2333721415595789){ref-type="table"}). Trials comparing a caregiver-involved intervention with attention controls, such as psychoeducation, showed few improvements on outcomes. Evidence was insufficient to suggest that interventions, beyond providing education and minimal support to caregivers, are beneficial to patients.

### Symptom control {#section22-2333721415595789}

Twelve trials reported symptom control outcomes. Of these, 3 reported significant differences in symptom control due to interventions ([@bibr3-2333721415595789]; [@bibr26-2333721415595789]; [@bibr34-2333721415595789]). Although 2 of the 3 were of good quality ([@bibr3-2333721415595789]; [@bibr34-2333721415595789]), none had significant effect sizes and instead reported either significant mean differences by intervention or reported *p* values without reporting data. All were narrowly focused interventions intended to change specific symptoms. They included a sleep hygiene intervention to improve patient sleep behavior ([@bibr34-2333721415595789]) and a toileting intervention to reduce incontinence ([@bibr26-2333721415595789]). The third included a comparison of one intervention to train caregivers to manage patient behavior with another intervention that taught caregivers self-care strategies to cope with caregiving burden ([@bibr3-2333721415595789]).

### Quality of life, physical and cognitive functioning, depression/anxiety, and utilization {#section23-2333721415595789}

Of the 15 trials, 12 assessed outcomes of interest other than symptom control. Of these, 4 trials showed significant differences between intervention and controls for any one outcome. One was a cognitive-behavioral intervention that improved physical functioning of patients by reducing environmental stressors at home ([@bibr18-2333721415595789]). The second was an intervention designed to improve patients' quality of life by enhancing their family members' skills in caregiving ([@bibr2-2333721415595789]). The third replicated the Mittelman study previously reported. The intervention, which included counseling and support specifically for adult children of care recipients, was effective at reducing or delaying placement in residential care for care recipients compared with attention controls. The fourth was the sleep hygiene study that reported significant differences by comparator group in patient depression, but using data provided, our calculated effect size was not significant ([@bibr34-2333721415595789]).

No harm to caregivers or patients was reported in any studies.

Long-Term Outcomes {#section24-2333721415595789}
------------------

Two trials ([@bibr13-2333721415595789]; [@bibr47-2333721415595789]) included long-term (at least 6 months post-intervention) follow-up. The first trial replicated the Mittelman trial and had similar findings to this earlier trial. Researchers found that the intervention was successful at keeping patients at home significantly longer. The time from baseline to residential placement for care recipients of caregivers in the control group was 228 days earlier than for the intervention group. In the second trial, comparisons between intervention and controls at 6 months were not reported, only changes within groups over time.

Discussion {#section25-2333721415595789}
==========

Family roles are significantly disrupted when an individual with cognitive impairment develops worsening function or symptoms. Functional decline typically means a greater demand on family caregivers for patient assistance, care management, and support. Thus, interventions that reduce caregiver burden and enhance patient assistance, care management, and support are important. Previous work has demonstrated the effectiveness of certain interventions on caregiver outcomes. In this review, we sought to determine whether caregiver interventions were effective at improving or reducing decline in *patient outcomes*, including functional status, quality of life, managing problem behaviors, and health care utilization. We did not identify specific types of interventions (i.e., training, training and support or unique interventions) that demonstrated greater mitigation of declines in or greater statistical improvement in patient outcomes than comparators, although we cannot rule out that clinically meaningful differences exist. Of the larger, good quality trials that showed significant effects on at least one outcome, interventions were tailored to the needs of patients and caregivers ([@bibr18-2333721415595789]) and included long-term, ongoing support ([@bibr13-2333721415595789]; [@bibr35-2333721415595789]).

The strength of evidence is low regarding the effectiveness of caregiver-involved interventions in improving patient outcomes in adults with dementia compared with usual care or wait list. We also did not find that caregiver-involved interventions were superior to the ones that are patient focused or provide only health education, support, or psychoeducation. Few trials with statistically significant findings have been replicated. The one exception is the New York University Caregiver Intervention (NYUCI), which in two trials (three articles; [@bibr13-2333721415595789]; [@bibr35-2333721415595789]; [@bibr36-2333721415595789]), with different comparator groups, showed significant effects of caregiver counseling and support in delaying institutionalization. Other trials that have not been replicated suggest that symptom control and depression/anxiety were outcomes most amenable to change. However, additional research is needed before recommending widespread adoption.

Previous research and reviews have been equivocal in their summative conclusions about the effects of caregiver interventions on outcomes for patients with dementia/Alzheimer's disease. Our review not only updates previous reviews but also provides a different perspective for examining the evidence. First, unlike previous reviews by [@bibr4-2333721415595789]; [@bibr50-2333721415595789]; and [@bibr37-2333721415595789], that included observational, quasi-experimental, and case studies, we included only RCTs. By reviewing evidence only from RCTs, we minimized the potential that reported effects may be due to secular trends or imbalances or from variations in patient or caregiver baseline characteristics, issues that cannot be controlled in non-randomized studies. Second, we assessed the evidence from trials that compared two different interventions instead of limiting the review only to interventions that were compared with usual care. Third, previous reviews also included studies conducted outside the United States. We limited our review to studies conducted in the United States to reflect the unique social, cultural, and clinical norms and resources for caregiver support that can vary across countries ([@bibr11-2333721415595789]; [@bibr50-2333721415595789]) and to better inform the public health needs outlined in the National Plan to Address Alzheimer's Disease ([@bibr51-2333721415595789]). Fourth, unlike other reviews that targeted a specific set of outcomes ([@bibr4-2333721415595789]; [@bibr37-2333721415595789]), we included a broad set of outcomes that affect patients with dementia. We included not only problem behaviors, such as wandering, aggression, and agitation but also patient depression and anxiety, quality of life and functional status. Finally, we included a broad range of psychosocial interventions targeting caregivers and did not limit the review to only trials that included face-to-face interventions for the caregiver/care recipient dyad ([@bibr52-2333721415595789]).

The evidence summarized in our review has limitations. Although the intention of each trial was not always stated, a number of studies in our review likely were designed to improve caregiver outcomes (e.g., reducing caregiver burden) and patient outcomes were secondary. For some interventions, it is likely that the intention was to reduce the burden of care for caregivers by helping them manage patient functioning and care. Consequently, their limited impact on patient outcomes is not surprising; such interventions were likely not explicitly designed to directly benefit patients. The Resources for Enhancing Alzheimer's Caregiver Health (REACH) trials, for example, have shown significant improvements in caregiver outcomes over comparators ([@bibr2-2333721415595789]; [@bibr12-2333721415595789]; [@bibr32-2333721415595789]), but patient outcomes examined for this review were not consistently different than comparators ([@bibr2-2333721415595789]; [@bibr17-2333721415595789]). It is possible that effective interventions targeting caregiver outcomes may subsequently benefit patients or slow the progression of poor outcomes, but the effect on families must be large enough to result in perceptible patient benefit and sufficient follow-up to detect subsequent patient effects. Our review did not include large-scale interventions or public-health-oriented programs, such as support lines, mass educational campaigns, or cash and counseling programs that families may use in ways that affect patient outcomes.

The National Plan to Address Alzheimer's Disease provides a charge to harness efforts to improve research quality and consistency of measurement and to more clearly define specific caregiver strategies to improve care quality, especially among high-risk groups, and fill gaps in the body of evidence. With these goals in mind, we have a number of recommendations for policy makers, researchers, and providers. First, other studies have shown that caregiver interventions can reduce caregiver burden ([@bibr45-2333721415595789]). However, it remains unclear if reducing caregiver burden enhances patient care, which, in turn, improves patient outcomes. Future research that can rigorously test this question is needed. Understanding the link between caregiver health and patient health is critical for understanding whether separate interventions should address caregiver issues and patient issues, or if investing in caregiver interventions will provide downstream improvements in patient outcomes. Second, more replication of good quality studies that have shown significant effects, such as those conducted by [@bibr36-2333721415595789] and [@bibr13-2333721415595789], which both have shown persistent effects over long periods of time, is critical to determine whether interventions can affect targeted outcomes in similar populations and subpopulations. Third, adequately powered research is needed to improve the precision of the estimated intervention effects. Likewise, improved documentation of methodology including blinding, allocation concealment, descriptions of dropouts by experimental group, and use of ITT analyses is needed to assess potential bias. In addition, consensus in the field about which criteria should be used to assess dementia severity and which instruments should be employed to assess common outcomes of interest would allow for meta-analysis of data that could help elucidate the net impact of interventions. Outcome data should be reported post-treatment for each comparator group for direct group comparison and, when feasible, longer term outcomes should be included to assess intervention sustainability and downstream effects of caregiver intervention on patient outcomes. Trials such as [@bibr48-2333721415595789], which did not show post-intervention effects, but did find significant differences at 6 months, may indicate a need to study if a lack of evidence is in part due to delayed interventions that are missed when long-term assessments are not included.

Conclusion {#section26-2333721415595789}
==========

We identified a wide range of interventions directed at caregivers of adults with dementia or Alzheimer's disease that also reported patient outcomes. Most were evaluated solely in single randomized trials. Variability in study populations, interventions, and outcomes precluded data pooling and limited generalizing findings from any single study. Harms appeared to be few but data were rarely reported. Although many did not demonstrate improved outcomes in adults with dementia or Alzheimer's disease compared with usual care or an active treatment, an intervention that combined counseling and support groups for caregivers, resulted in persistent delays in nursing home placement. However, current evidence does not demonstrate that most caregiver interventions provide consistent or clinically meaningful improvements for adults with dementia or Alzheimer's disease. Additional research is needed before widespread implementation of caregiver interventions can be implemented if the goal is to improve outcomes in patients with dementia or Alzheimer's disease.
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